TNF and rheumatoid arthritis: Studies show that while glucocorticoids may predispose to skin fragility and thus serve as a risk factor for ulceration in patients with RA, more aggressive therapy for the underlying RA, using disease-modifying antirheumatic drugs (DMARD) and biologic agents such as tumor necrosis factor-alpha inhibitors and rituximab is beneficial [6].